J F van den Bosch - JoVE Visualize

Showing results (11-20 of 41) with videos related to

Pageof 5

Sort By:

Journal of Cell Science|August 1, 1976

Surface morphology and agglutination of lectin-treated human lymphocytes and lymphoblastsJ H Temmink, J G Collard, J Roosien, et al.

Molecular and Cellular Probes|August 1, 1995

Development of an efficient PCR method for toxin typing of Actinobacillus pleuropneumoniae strainsJ Frey, M Beck, J F van den Bosch, et al.

Antonie Van Leeuwenhoek|January 1, 1984

Ribonuclease-sensitive ribosomal vaccinesR Gonggrijp, A C Antonissen, J F van den Bosch, et al.

Veterinary Microbiology|February 9, 2000

Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniaeR Nielsen, J F van den Bosch, T Plambeck, et al.

Antonie Van Leeuwenhoek|January 1, 1986

Dissociation between enhanced resistance and delayed hypersensitivity induced with subcellular preparations from Listeria monocytogenes and the adjuvant dimethyl-dioctadecyl-ammonium bromideA C Antonissen, P J Lemmens, J F van den Bosch, et al.

Immunology Letters|November 17, 1986

Transfer of enhanced resistance against Listeria monocytogenes induced with ribosomal RNA and the adjuvant dimethyldioctadecylammonium bromideA C Antonissen, P J Lemmens, J F van den Bosch, et al.

Neuroimage|March 22, 2019

The spatiotemporal neural dynamics underlying perceived similarity for real-world objectsRadoslaw M Cichy, Nikolaus Kriegeskorte, Kamila M Jozwik, et al.

Journal of Medical Microbiology|May 1, 1983

K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse modelA M Verweij-van Vught, J F van den Bosch, F Namavar, et al.

Antonie Van Leeuwenhoek|January 1, 1985

RNase-sensitive and RNase-insensitive protective components isolated from Listeria monocytogenesA C Antonissen, P J Lemmens, R Gonggrijp, et al.

Plos One|February 24, 2017

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performanceK D S Fernald, H P G Pennings, J F van den Bosch, et al.

Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:

Pageof 5

Journal of Cell Science|August 1, 1976

Surface morphology and agglutination of lectin-treated human lymphocytes and lymphoblastsJ H Temmink, J G Collard, J Roosien, et al.

Molecular and Cellular Probes|August 1, 1995

Development of an efficient PCR method for toxin typing of Actinobacillus pleuropneumoniae strainsJ Frey, M Beck, J F van den Bosch, et al.

Antonie Van Leeuwenhoek|January 1, 1984

Ribonuclease-sensitive ribosomal vaccinesR Gonggrijp, A C Antonissen, J F van den Bosch, et al.

Veterinary Microbiology|February 9, 2000

Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniaeR Nielsen, J F van den Bosch, T Plambeck, et al.

Antonie Van Leeuwenhoek|January 1, 1986

Dissociation between enhanced resistance and delayed hypersensitivity induced with subcellular preparations from Listeria monocytogenes and the adjuvant dimethyl-dioctadecyl-ammonium bromideA C Antonissen, P J Lemmens, J F van den Bosch, et al.

Immunology Letters|November 17, 1986

Transfer of enhanced resistance against Listeria monocytogenes induced with ribosomal RNA and the adjuvant dimethyldioctadecylammonium bromideA C Antonissen, P J Lemmens, J F van den Bosch, et al.

Neuroimage|March 22, 2019

The spatiotemporal neural dynamics underlying perceived similarity for real-world objectsRadoslaw M Cichy, Nikolaus Kriegeskorte, Kamila M Jozwik, et al.

Journal of Medical Microbiology|May 1, 1983

K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse modelA M Verweij-van Vught, J F van den Bosch, F Namavar, et al.

Antonie Van Leeuwenhoek|January 1, 1985

RNase-sensitive and RNase-insensitive protective components isolated from Listeria monocytogenesA C Antonissen, P J Lemmens, R Gonggrijp, et al.

Plos One|February 24, 2017

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performanceK D S Fernald, H P G Pennings, J F van den Bosch, et al.

Pageof 5